Marijuana Sector News

0 800
marijuana

$UBQU Premieres New 24 Hour Interactive Customer Support Phone System

 

Ubiquitech Software Corp. ( OTC PINK : UBQU ), through its operating subsidiary HempLife Today™, is announcing the development and implementation of its new IVR (Interactive Voice Response), 24 hour toll-free customer support phone system, developed to improve customer support, customer satisfaction, and increase sales volume.

This new IVR system was developed using one of the most technologically advanced software applications in the industry, and will help the Company to better serve its daily increase of customers for its growing line of CannazALL™ CBD products derived from Hemp, by offering an easier way to learn more about the Company, the products, and to better speak to a specialist who can assist in taking an order.


Click Here Now To Read Full PR


7 Cannabis Company Developments to Highlight

This week was a busy week for cannabis stocks and this is important as it follows a couple rough weeks of trading. Some of the important develops we think investors should take note of, include…[continue reading]


Click Here Now To Read Full Article


#ICYMI: Will This Marijuana Stock See a Record Setting Year in 2017?

Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU). Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year. What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.


Click Here Now To Read Full Article


 

Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 6800

Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU).  Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year.  What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.

Earlier this morning the company put out preliminary guidance on what it is anticipating to be a banner year ahead.  According to the release, the company anticipates that revenues for the year ending November 30, 2017 will increase over 55% from $3,493,113, which was reported in the annual period ended November 30, 2016 to approximately $5,450,000.

Ubiquitech Gives Fiscal Year 2017 Revenue Guidance; Anticipates 55% Year Over Year Increase To $5,450,000

“We are very pleased with the progress we have made and we will continue to do everything within our power to keep our company relevant and growing” said James Ballas, CEO “With the quality of our products, our marketing, customer support and satisfaction, and our dynamic thinking, we will continue this growth through 2017 and into 2018, which we are already planning big things for, and this is the thinking that will take our revenues to even higher gains as we continue. It’s a very exciting industry and we don’t plan to stop until the CannazALL brand is a household word.”

(UBQU) is no stranger to growth.  If you’re just pulling up the company’s other headlines, you’ll already notice major strides being made on the product end. Toward the beginning of the year, the company announced that it had concluded negotiations and reached an agreement to expand its hemp growing capabilities through an additional 140 acres of available hemp operations. They’ve also expanded their current product line to include brand new offerings.

But back to growth…Had this been a random company with its first press release in history, we might be a bit skeptical but (UBQU) has already proven its ability to run a multi-million dollar business that has managed to grow significantly just within the last year alone. On top of bullish guidance for the year ahead, (UBQU) is also coming off of a strong year and noticeable earnings growth.

Revenues for the last quarter increased to $1,225,015 and to $3,493,113 for the year. But what’s more is that net income increased over 700% from the previous year to $334,350 from $39,651 in 2015. First quarter guidance has already come in bullish on its own with the company expecting revenues for the quarter ended February 28, 2017 to increase over 50% from $697,640 in the first quarter of last year to approximately $1,050,000.

Of course this is just initial guidance and with the year ahead, nothing is set in stone. But one thing is certain and that based on the last releases from the company, (UBQU) has set itself on a growth trend.  So this bullish guidance could be shedding some light on what’s to come for this company in the very near term.

The opportunity for taking advantage of the growth that CBD is beginning to see, could be important to take into consideration.  We’ve previously written about this market and how it could be on a path for growth.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.  Think about this for a moment: (UBQU) is already growing and is expecting to continue this growth to the tune of 50+% for the year according to today’s announcement…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth. Having already come off of a banner year, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to moving into the coming weeks/months/quarters.

Again, you can access today’s (UBQU) news here:

Ubiquitech Gives Fiscal Year 2017 Revenue Guidance; Anticipates 55% Year Over Year Increase To $5,450,000

Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Full Disclaimer Here

 

 

 

0 1160
cannabis biotech


$FFRMF Acquires High Volume, State-of-the-Art Cannabis Oil Extraction Equipment

 

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (FFRMF) (FFT.CN) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, has purchased a state-of-the-art extraction machine, for the manufacture of concentrated cannabis oil and purified distillate.

The equipment purchased is designed to rapidly manufacture premium cannabis oil, to supply the growing demand for cannabis concentrates, in the state of California. The equipment utilizes a closed-loop system, to produce high quality oil in a high throughput system with minimal maintenance and labor. The equipment is estimated to be delivered, installed and in full production within the next 90 days.

 


Click Here Now To Read Full PR


 

San Francisco May Form Cannabis Commission And Cannabis Department

 

Supervisor Jeff Sheehy, who Mayor Ed Lee appointed to the District 8 post in January, introduced legislation last week that would create a seven-member Cannabis Commission and Cannabis Department with a director and staff in San Francisco. The commission will decide whether to grant or deny permits related to commercial cannabis businesses as well as decide whether to suspend such permits based on yet-to-be-developed guidelines. San Francisco is currently working on regulations for the recreational cannabis industry after California voters legalized the substance by passing Proposition 64 back in November.


Click Here Now To Read Full Article


 

Marijuana Stocks Especially Cannabis-Biotechs are Capturing Wall Street’s Attention in a Big Way

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage. Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.


Click Here Now To Read Full Article


 

Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1184

$VPRB LP is excited to release its new limited edition ProBox Kit

VPR Brands, LP (OTC PINK:VPRB) proudly introduces The Honey Stick limited edition ProBox kit, the all-in-one arsenal for everything herb, oil or wax related. The ProBox is the anything, anywhere, portable, mobile, stay home or travel kit and is the ultimate cannabis connoisseur dream kit.


Click Here Now To Read Full PR


Research Suggests People Favor Medical Marijuana Over Prescription Medications

Research published in the International Journal of Drug Policy has discovered that people taking psychoactive medications and drugs for conditions such as chronic pain seem to prefer medical cannabis to other drugs, including sedatives, opioids, and antidepressants.

Many analysts have expressed worry about the use of opioids to treat chronic pain. More than 183,000 people died of prescription opioid overdoses between 1999 and 2015 in the U.S. Some research, such as a recent study that looked at states with medical cannabis laws, suggests access to medical marijuana could reduce opioid abuse. The research used survey data from 271 people registered to purchase medical cannabis. Participants answered 107 questions covering demographic data, use of cannabis, reliance on other drugs, and health history.


Click Here Now To Read Full Article


Cannabis Could Be Legal In Every State By 2021


The marijuana industry is growing rapidly, as lawmakers in more states pass legislation making it legal. Twenty eight states have legalized medical cannabis, and eight states have passed recreational. According to the latest research by GreenWave Advisors, those numbers are about to greatly increase. Last November’s election transformed the cannabis state map. Ahead of the election, voters in only four states (Alaska, Colorado, Washington, and Oregon) had voted to establish recreational markets for use of marijuana, and twenty four states had passed medical cannabis laws.


Click Here Now To Read Full Article


Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 90 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $45,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. We may buy or sell additional shares of (VPRB) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1087

Quality Of Cannabis Issued By Government Affecting Scientists’ Research

The quality of the cannabis the United States government provides to scientists may be impacting the results of their studies, experts say. The issue made national headlines after Dr. Sue Sisley, a researcher with the Multidisciplinary Association for Psychedelic Studies (MAPS), shared photos of the marijuana provided by the only facility licensed by the Drug Enforcement Administration to produce cannabis for clinical research. The facility is located at the University of Mississippi and is run by the National Institute on Drug Abuse (NIDA).


Click Here Now To Read Full Article


Marijuana As A Glaucoma Treatment; Does It Really Work?

 

Research has shown that cannabinoids can alleviate glaucoma-related symptoms because they lower the intraocular pressure (IOP) and have neuroprotective actions. For example, in 1971, one of the first studies of its kind found ingestion of cannabis lowers IOP by 25 to 30%. Despite the findings from early research, very few ophthalmologists support the use of medical cannabis in patients with early to mid-stage glaucoma. The main issue ophthalmologists have with marijuana is that the potential adverse effects, particularly smoking cannabis, outweigh the short term benefits. For example, smoking can lead to unstable intraocular pressure, which heightens the risk of permanent vision loss.


Click Here Now To Read Full Article


 

Marijuana Industry Takes A Step Forward Towards Validity And Long-Term Stability

The marijuana industry is getting ready to take a step forward in its venture for validity and long-term stability. The American Society for Testing and Materials (ASTM International) recently announced that it will put a committee of industry representatives and experts together to create a set of guidelines in six technical areas: Indoor and outdoor horticulture and agriculture, Quality management systems, Laboratory standards, Processing and handling, Security and transportation, Personal training/ assessment and credentialing.


Click Here Now To Read Full Article


0 2248
marijuana_glaucoma

Research has shown that cannabinoids can alleviate glaucoma-related symptoms because they lower the intraocular pressure (IOP) and have neuroprotective actions. For example, in 1971, one of the first studies of its kind found ingestion of cannabis lowers IOP by 25 to 30%. Despite the findings from early research, very few ophthalmologists support the use of medical cannabis in patients with early to mid-stage glaucoma. The main issue ophthalmologists have with marijuana is that the potential adverse effects, particularly smoking cannabis, outweigh the short term benefits. For example, smoking can lead to unstable intraocular pressure, which heightens the risk of permanent vision loss.

Additionally, because its therapeutic effects on glaucoma are short-term, patients would have to consume marijuana frequently; once every three to four hours. Physicians claim that because glaucoma needs to be treated 24 hours per day, patients would need to consume marijuana six to eight times over the course of a day to achieve consistently decreased IOP levels. Such frequency is difficult to maintain and could heighten the risk of developing a marijuana use disorder. However, when it comes to late stage glaucoma, ophthalmologists are more inclined to embrace cannabis as a treatment. At the end stages of glaucoma, it is less about directly targeting the glaucoma and more about alleviating the accompanying symptoms.

Ophthalmologist Andrew Bainnson, MD stated, “We’ve known for some time that medical marijuana is very effective for treating nausea and pain, but not so much for glaucoma. However, there are some patients with end stage pain and nausea who may benefit [from medical marijuana], but not from the glaucoma point of view.” The body’s own internal cannabinoid system, called the endocannabinoid system (ECS), is one of our most important physiological systems. Nearly every aspect of our health including: inflammation, immune response, neuroprotection, pain modulation, are all dependent on the ECS. Given the vital role of the ECS, particularly in neuroprotection and inflammation, many scientists believe the development of cannabinoid-based medications may be useful in treating glaucoma.

1 2761

Cannabis shops and manufacturers have increasing concerns that the Trump Administration will enforce federal laws that restrict farming and selling the drug. This will reverse the president’s stance during his campaign and potentially overturn what has become a $7 billion industry. The worry was provoked by comments from White House spokesman Sean Spicer recently that the government would most likely boost its enforcement of drug laws.

Attorney General Jeff Sessions stated that he is “dubious” about the benefits of marijuana. He said, “Marijuana is against federal law, and that applies in states where they may have repealed their own anti-marijuana laws. So yes, we will enforce law in an appropriate way nationwide. It’s not possible for the federal government, of course, to take over everything the local police used to do in a state that’s legalized it. And I’m not in favor of legalization of marijuana. I think it’s a more dangerous drug than a lot of people realize.”

The comments have sparked worry with Chuck Smith, co-founder of Dixie Brands, a Denver-based company that manufactures topicals and edibles infused with THC, the active ingredient in cannabis. He founded the company in 2010 and now employs more than 100 people across Arizona, Colorado, California, and Nevada. Smith stated, “My concern right now for both the company and industry is just uncertainty. It’s hard to build an industry or a company when you don’t have clarity.”

The administration’s statements affected shares of Innovative Industrial Properties, which invests in cannabis-growing facilities and is one of the few publicly traded cannabis companies. Its stock price plummeted on the day of Spicer’s press conference and are down more than 13% since then. However, two other marijuana stocks, GW Pharmaceuticals and Cara Therapeutics, seem to have not been affected by the news.

Eight states now allow the use of cannabis recreationally, while more than two dozen states have legalized it for medical purposes. Twenty-one states have decriminalized cannabis. A recent Quinnipiac Poll found 71% of voters think the government should not restrict federal drug laws in states where marijuana is legal. Increasing acceptance has led to an jump in the market for cannabis in North America, with sales rising 34% to nearly $7 billion in 2016, according to Arcview Market Research. By 2021, the industry is likely to climb close to $22 billion.

Companies like Dixie Brands are charging that hike. The privately held company would not disclose current numbers, but in 2014 it was valued at $40 million. Smith said, “It’s hard for us to kind of go backwards. President Trump said he was going to allow this to be a state’s rights issue. We took him at his word.” Trump has sent mixed messages on cannabis. In the 1990s, he called for legalizing all drugs. On the campaign trail, he reiterated his support for medical cannabis and his deference to states to pass their own laws regulating the drug.

2 1793

The cannabis industry continues to face threats from Attorney General Jeff Sessions as his campaign against cannabis continued this week.

The AG recently said, “I realize this may be an unfashionable belief in a time of growing tolerance of drug use. But too many lives are at stake to worry about being fashionable. I reject the idea that America will be a better place if marijuana is sold in every corner store. And I am astonished to hear people suggest that we can solve our heroin crisis by legalizing marijuana – so people can trade one life-wrecking dependency for another that’s only slightly less awful. Our nation needs to say clearly once again that using drugs will destroy your life.”

Sessions should take a lesson from Joe Rogan. In a YouTube video, Rogan said, “The only reason why marijuana is illegal is because of economics. If marijuana was legal, it would cost pharmaceutical and alcohol companies billions of dollars every year. The Partnership for a Drug-Free America is funded by alcohol companies. Alcohol is a sanctioned drug”

Marijuana can treat several debilitating diseases and improve the daily life of millions of people around the world.

Ten illnesses that can be treated by marijuana

1.Marijuana can be used to treat and prevent glaucoma. According to the National Eye Institute, marijuana decreases the pressure inside the eye. “Studies in the early 1970s showed that marijuana, when smoked, lowered intraocular pressure (IOP) in people with normal pressure and those with glaucoma.”

2.Marijuana helps reverse the carcinogenic effects of tobacco and improves lung health. In January 2012, a study was published in Journal of the American Medical Association which said marijuana does not impair lung function and it can even increase lung capacity.

3.Marijuana can help control epileptic seizures. Charlotte Figi suffers from Dravet’s Syndrome and a strain of marijuana called “Charlotte’s Web” has decreased Charlotte’s seizures from 300 a week to just one every seven days.

4.Marijuana can decrease anxiety. In 2010, researchers at Harvard Medical School suggested that that some of marijuana’s benefits may be associated with reduced anxiety.

5.THC slows the progression of Alzheimer’s disease. A study led by Kim Janda of the Scripps Research Institute suggests that marijuana may be able to slow the progression of Alzheimer’s disease. In 2006, the study published in the journal of Molecular Pharmaceutics found that THC, the active chemical in marijuana, slows the formation of amyloid plaques by blocking the enzyme in the brain that makes them. These plaques are what kill brain cells and cause Alzheimer’s.

6.Marijuana helps ease the pain associated with multiple sclerosis. GW Pharmaceuticals (GWPH) has developed a drug derived from cannabis called Sativex which helps patients who suffer from multiple sclerosis.

7. Marijuana relieves arthritis discomfort. In 2011, researchers said that marijuana alleviates pain, reduces inflammation and promotes sleep, which may help relieve pain for people suffering from rheumatoid arthritis.

8.Marijuana can potentially eliminate Crohn’s disease. A study in Israel showed that smoking a joint significantly reduced Crohn’s disease symptoms in 10 out of 11 patients. Marijuana caused a complete remission in five of the patients.

9.Marijuana helps veterans suffering from PTSD. The Department of Health and Human Services recently signed off on a proposal to study marijuana’s potential as part of the treatment for veterans with post-traumatic stress disorder.

10.Marijuana reduces some of the pain and nausea from chemotherapy and stimulates appetite.

0 1599

$VPRB Brands will be participating in the upcoming ASD Market Week Show

VPR Brands, LP (OTC PINK: VPRB) is looking forward to attending the ASD market week trade show starting on Sunday March 19 and ending Wednesday March 22, 2017 in booth # SL3564 at the Las Vegas Convention Center. VPR Brands will be featuring its HELIUM Brand eliquid www.vapehelium.com and its HONEY STICK Brand Vaporizer line www.vapehoneystick.com as well as its new all in one smoke kit the ALPHA-PUFF www.alphapuff.com and the KUSH ARMY KNIFE the must have multi tool gadget for smokers www.kusharmyknife.com.


Click Here Now To Read Full PR


$VNNYF Develops a Disruptive Solvent Based Extraction System

 

Vinergy Resources Ltd. (“Vinergy” or the “Company”) (CSE:VIN) (OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce it has developed a disruptive solvent based extraction system. The project currently underway for an existing customer, utilizes an ethanol / CO2 co-solvent blend and specialized equipment to achieve medicinal products with significantly increased purity. The current iteration of the machine has the physical footprint of a standard shipping skid and incorporates safety and process control systems in one easy to use platform.


Click Here Now To Read Full PR


$IMLFF Announces Publication of Discussion on the R&D of Cannabinoids

 


NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals ( CSE : IN ) ( OTCQB : IMLFF ), an NNW client that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.

The publication, entitled, “Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth,” discusses the rampant growth of the cannabis market and how a number of biotech companies are developing cannabinoid-based therapies to address unmet medical needs.

 


Click Here Now To Read Full PR


Can CBD Yield A Positive Result On A Drug Test?


CBD is well-known for its health benefits, especially in treating rare seizure disorders. There are other reasons people try CBD products, also. A neurologist and psychopharmacology researcher, Dr. Ethan Russo, notes in a study that the therapeutic effects of CBD are broad, including: analgesic, anti-inflammatory, antiemetic, antioxidant, anti-psychotic, anti-anxiety, anti-convulsant and cytotoxic in certain cancer cells. Typically, CBD products are primarily made from the concentrated extract of the flowers, leaves and possibly stalks of marijuana or hemp. Most CBD products are either oil-based tinctures or capsules that are consumed orally, or topicals applied to the skin. However, there is a growing variety of other products containing CBD, including those for pets.

 


Click Here Now To Read Full Article


 

 

Pursuant to an agreement between MAPH and InMedPharmaceuticals., we were hired for a period beginning February 24 2017 and ending April 24, 2017 to publicly disseminate information about (IMLFF) including on the Website and other media including Facebook and Twitter. We are being paid $40,000 (CASH) for and were paid “250,000” shares of restricted common shares of InMed Pharmaceuticals.Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 90 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $45,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. Pursuant to an agreement between MAPH and Vinergy Resources, we were hired for a period of 2 months to publicly disseminate information about (VNNYF) including on the Website and other media including Facebook and Twitter. We are being paid $120,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (VNNYF) which we purchased in the open market. We may buy or sell additional shares of (IMLFF, VPRB, VNNYF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

1 1541

$FFRMF to Manage Cannabis Cultivation Facility

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB:FFRMF) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, a California limited liability company, has entered into a management agreement with a California non-profit company. The non-profit has secured a sublease for the purpose of cultivating premium grade cannabis in Riverside County, California. The cultivation facility will supply its high-quality cannabis to the previously announced extraction facility where it will be further processed into premium grade concentrates.


Click Here Now To Read Full PR


Marijuana Industry Takes A Step Forward

The marijuana industry is getting ready to take a step forward in its venture for validity and long-term stability. The American Society for Testing and Materials (ASTM International) recently announced that it will put a committee of industry representatives and experts together to create a set of guidelines in six technical areas: Indoor and outdoor horticulture and agriculture, Quality management systems, Laboratory standards, Processing and handling, Security and transportation, Personal training/ assessment and credentialing.

 


Click Here Now To Read Full Article


Doctors Share Experience With CBD And Children Suffering From Autism

Physicians will not prescribe marijuana to treat autism in children because no information exists to support such a course of therapy . However, the research does not exist because of medical establishment worries about marijuana testing, with its many active compounds seen as conceivably uncontrollable variables, on children. In the absence of practical information, however, is a growing body of anecdotal proof that marijuana is making autistic children healthier and happier. Some physicians are listening.


Click Here Now To Read Full Article


Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements